Mobara, Japan

Hiroshi Kawazura


Average Co-Inventor Count = 7.8

ph-index = 4

Forward Citations = 37(Granted Patents)


Location History:

  • Chiba, JP (1989 - 1991)
  • Mobara, JP (1983 - 1992)

Company Filing History:


Years Active: 1983-1992

Loading Chart...
12 patents (USPTO):Explore Patents

Title: Hiroshi Kawazura: Innovator in Therapeutic Compounds

Introduction

Hiroshi Kawazura is a prominent inventor based in Mobara, Japan, known for his significant contributions to the field of therapeutic agents. With a total of 12 patents to his name, Kawazura has focused much of his work on innovative pharmaceutical compounds, particularly in the area of cerebrovascular health.

Latest Patents

Among his latest patents, Kawazura has developed novel (-)-2-pyrazoline compounds that serve as effective therapeutic agents. Notably, one of his inventions relates to a method for optically resolving 1-(3-pyridylcarbonyl)-5-methyl-2-pyrazoline. This advancement not only showcases his inventiveness but also emphasizes the potential impact of his work in the pharmaceutical industry.

Career Highlights

Kawazura has held significant roles at established companies such as Mitsui Toatsu Chemicals, Incorporated and Mitsui Toatsu Kagaki Kabushiki Kaisha. His experience in these organizations has allowed him to refine his expertise in chemical engineering and therapeutic development.

Collaborations

Throughout his career, Kawazura has collaborated with talented individuals including Yutaka Okazaki and Seitaro Kajiya. Their joint efforts have likely contributed to the innovative nature of his work and the successful execution of his patents.

Conclusion

Hiroshi Kawazura stands as an influential figure in the realm of therapeutic innovations. His ongoing research and patent developments reflect his dedication to improving health outcomes, especially within cerebrovascular treatment. As he continues to innovate, the impact of his work will likely resonate within the medical and scientific communities.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…